Oct 30, 2024 4:15pm EDT Processa Pharmaceuticals Reports Third Quarter Business Highlights and Financial Results
Oct 2, 2024 4:05pm EDT Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer